人工胰脏: 现状、挑战与展望

doi:10.3969/j.issn.0258-8021.2013.03.015

摘要
图/表
参考文献
相关文章 (5)

全文: PDF (791 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目前医学界还没有根治糖尿病的手段，人工胰脏被广泛地认为是治疗和管理糖尿病最有前途的手段之一。在此就动态血糖监测系统（CGMS）、胰岛素泵、闭环算法、及其之间的通信和临床试验等5个方面，对人工胰脏研究的发展现状进行了综述，并对所面临的挑战以及有前途的研究方向进行了讨论。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	王友清^*

关键词 ：人工胰脏, 糖尿病, 闭环控制, 胰岛素, 动态血糖监测系统（CGMS）

Abstract：There are currently no radical treatment methods 　for diabetes mellitus, and artificial pancreas (AP) system is widely considered one of the most promising candidates for diabetes daily management. A survey on the stateoftheart, challenges, and promising directions for AP research was presented in this paper, in terms of continuous glucose monitoring system (CGMS), insulin pump, closedloop algorithm, communication, and clinical trials.

Key words： artificial pancreas diabetes mellitus closedloop control insulin continuous glucose monitoring system (CGMS)

基金资助:国家自然科学基金（61074081）; 北京市科技新星（2011025）; 霍英东青年教师基金（131060）

引用本文:

王友清^*. 人工胰脏: 现状、挑战与展望[J]. 中国生物医学工程学报, 2013, 32(3): 363-372.
WANG You Qing^*. Artificial Pancreas: StateoftheArt, Challenges and Outlook. journal1, 2013, 32(3): 363-372.

链接本文:

http://cjbme.csbme.org/CN/10.3969/j.issn.0258-8021.2013.03.015 或 http://cjbme.csbme.org/CN/Y2013/V32/I3/363

［1］International Diabetes Federation. IDF diabetes atlas (5th edition) ［EB/OL］. http://www.diabetesatlas.org, 2011-11-14/2012-07-01. 
［2］Clemens AH, Chang PH, Myers RW. The development of Biostator, a glucose controlled insulin infusion system (GCIIS) ［J］. Horm Metab Res Suppl, 1977, 7: 23-33.
［3］Kovatchev B, Anderson S, Heinemann L, et al. Comparison of the numerical and clinical accuracy of four continuous glucose monitors ［J］. Diabetes Care， 2008,　31: 1160-1164.
［4］Zisser H, Robinson L, Bevier W, et al. Bolus calculator: a review of four “smart” insulin pumps ［J］. Diabetes Technol Ther， 2008,　10: 441-444.
［5］Artificial pancreas project ［EB/OL］. http://www.artificialpancreasproject.com, 2005-08-01/2012-03-15. 
［6］Small business innovation research to develop new therapeutics and monitoring technologies for type 1 diabetes (T1D) towards an artificial pancreas ［EB/OL］. http://grants.nih.gov/grants/guide/rfafiles/RFADK09001.html, 2008-12-10/2012-03-15. 
［7］Artificial pancreas (AP) at home ［EB/OL］. http://www.apathome.eu, 2010-02-01/2012-07-01. 
［8］Zhou J, Li H, Ran XW, et al. Reference values for continuous glucose monitoring in Chinese subjects ［J］. Diabetes Care， 2009,　32: 1188-1193.
［9］Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China ［J］. The New England Journal of Medicine， 2012, 362: 1090-1101.
［10］姜利英, 任丽洁, 陈青华, 等. 血糖检测技术研究进展［J］. 传感器世界， 2009,　10: 6-10, 31.
［11］Ho H, Saeedi E, Kim SS, et al. Contact lens with integrated inorganic semiconductor devices ［C］ // 21st IEEE International Conference on MicroElectroMechanical Systems (MEMS). Tucson, Arizona, 2008: 403-406.
［12］Garg SK, Smith J, Beatson C, et al. Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems ［J］. Diabetes Technology & Therapeutics， 2009,　11(2): 65-72.
［13］Kamath A, Mahalingam A, Brauker J. Analysis of time lags and other sources of error of the DexCom SEVEN continuous glucose monitor ［J］. Diabetes Technol Ther， 2009,　11: 689–695.
［14］Garg SK, Voelmle M, Gottlieb PA. Time lag characterization of two continuous glucose monitoring systems ［J］. Diabetes Res Clin Pract， 2010,　87: 348-353.
［15］Keenan DB, Mastrototaro JJ, Voskanyan G, et al. Delays in minimally invasive continuous glucose monitoring devices: a review of current technology ［J］. J Diabetes Sci Technol， 2009, 3: 1207–1214.
［16］Jakisch BI, Wagner VM, Heidtmann B, et al. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric type 1 diabetes: a multicentre matchedpair cohort analysis over 3 years ［J］. Diabetic Medicine， 2008,　25: 80-85.
［17］Bruttomesso D, Costa S, Baritussio A. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy ［J］. Diabetes Meta Res Rev， 2009,　25: 99-111.
［18］Steiner S, Hompesch M, Pohl R, et al. A novel insulin formulation with a more rapid onset of action ［J］. Diabetologia， 2008,　51: 1602-1606.
［19］Bequette BW. A critical assessment of algorithms and challenges in the development of a closedloop artificial pancreas ［J］. Diabetes Technol Ther， 2005,　7: 28-47.
［20］Parker RS, Doyle III FJ, Peppas NA. A modelbased algorithm for blood glucose control in type I diabetic patients ［J］. IEEE Trans Biomed Eng， 1999,　46: 148-157.
［21］Hovorka R, Canonico V, Chassin LJ, et al. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes ［J］. Physiol Meas， 2004,　25(4): 905-920.
［22］Wang Y, Zisser H, Dassau E, et al. Model predictive control with learningtype setpoint: application to artificial pancreatic betacell ［J］. AIChE J， 2010,　56: 1510-1518.
［23］Marchetti G, Barolo M, Jovanovi?倣 L, et al. An improved PID switching control strategy for type 1 diabetes ［J］. IEEE T Biomed Eng， 2008,　55: 857-865.
［24］Clemens AH. Feedback control dynamics for glucose controlled insulin infusion system ［J］. Med Prog Technol， 1979,　6: 91-98.
［25］Atlas E, Nimri R, Miller S, et al. MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes ［J］. Diabetes Care， 2010,　33: 1072-1076.
［26］Mauseth R, Wang Y, Dassau E, et al. Proposed clinical application for tuning fuzzy logic controller of artificial pancreas utilizing a personalization factor ［J］. J Diabetes Sci Technol， 2010,　4(4): 913-922.
［27］ElKhatib FH, Jiang J, Damiano ER. Adaptive closedloop control provides bloodglucose regulation using dual subcutaneous insulin and glucagon infusion in diabetic Swine ［J］. J Diabetes Sci Technol， 2007,　1: 181-192.
［28］RodríguezHerrero A, PérezGandía C, Rigla M, et al. A simulation study of an inverse controller for closed and semiclosedloop control in type 1 diabetes ［J］. Diabetes Technol Ther， 2010,　12(2): 95-104.
［29］Wang Y, Dassau E, Zisser H, et al. Automatic bolus and adaptive basal (ABAB) algorithm for the artificial pancreatic βcell ［J］. Diabetes Technol & Ther， 2010: (in press).
［30］Kiam Heong A, Chong G, Yun L. PID control system analysis, design, and technology ［J］. Control Systems Technology, IEEE Transactions on， 2005,　13(4): 559-576.
［31］Ellingsen C, Dassau E, Zisser H, et al. Safety constraints in an artificial pancreatic beta cell: an implementation of model predictive control with insulin on board ［J］. J Diabetes Sci Technol， 2009,　3(3): 536-544.
［32］Hovorka R, Allen JM, Elleri D, et al. Manual closedloop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial ［J］. The Lancet， 2010,　375: 743-751.
［33］Buckingham B, Cobry E, Clinton P, et al. Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension ［J］. Diabetes Technol Ther， 2009,　11: 93-97.
［34］王友清, 脱建勇. 网络丢包时“人工胰脏”的可靠控制［J］. 南京航空航天大学学报， 2011,　43(S): 194-198.
［35］Dalla Man C, Breton MD, Cobelli C. Physical activity into the meal glucoseinsulin model of type 1 diabetes: in silico studies ［J］. J Diabetes Sci Technol， 2009,　3: 56-67.
［36］Kovatchev BP, Breton M, Dalla Man C, et al. In silico preclinical trials: a proof of concept in closedloop control of type 1 diabetes ［J］. J Diabetes Sci Technol， 2009,　3: 44-55.
［37］Wilinska ME, Chassin LJ, Acerini CL, et al. Simulation environment to evaluate closedloop insulin delivery systems in type 1 diabetes ［J］. J Diabetes Sci Technol， 2010,　4(1): 132-144.
［38］ZlKhatib FH, Russell SJ, Nathan DM, et al. A bihormonal closedloop artificial pancreas for type 1 diabetes. ［J］. Sci Transl Med， 2010,　2: 27ra27.
［39］Dassau E, Zisser H, Palerm CC, et al. Modular artificial betacell system: a prototype for clinical research ［J］. J Diabetes Sci Technol， 2008,　2(5): 863-872.
［40］Raymond, N. Artificial pancreas a realworld success ［EB/OL］. http://www.medicine.virginia.edu/research/institutesandprograms/cdt/artificalpancreastechnology, 2011-11-21/2012-07-01. 
［41］Elleri D, Dunger DB, Hovorka R. Closedloop insulin delivery for treatment of type 1 diabetes ［J］. BMC Medicine， 2011,　9: 120-128.
［42］Buckingham B, Chase HP, Dassau E, et al. Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension ［J］. Diabetes Care， 2010,　33: 1013-1017.
［43］Choudhary P, Shin J, Wang Y, et al. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk ［J］. Diabetes Care， 2011,　34: 2023-2025.
［44］Danne T, Kordonouri O, Holder M, et al. Prevention of hypoglycemia by using low glucose suspend function in sensoraugmented pump therapy ［J］. Diabetes Technol Ther， 2011,　13: 1-6.
［45］Hovorka R, Kumareswaran K, Harris J, et al. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies ［J］. BMJ， 2011,　342: d1855.
［46］Steil GM, Palerm CC, Kurtz N, et al. The effect of insulin feedback on closed loop glucose control ［J］. J Clin Endocrinol Metab， 2011,　96: 1402-1408.
［47］Murphy HR, Elleri D, Allen JM, et al. Closedloop insulin delivery during pregnancy complicated by type 1 diabetes ［J］. Diabetes Care， 2011,　34: 406-411.
［48］Murphy HR, Kumareswaran K, Elleri D, et al. Safety and efficacy of 24 h closedloop insulin delivery in wellcontrolled pregnant women with type 1 diabetes: a randomized crossover case series ［J］. Diabetes Care， 2011,　34(12): 2527-2529.
［49］Liebl A, Hoogma R, Renard E, et al. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion ［J］. Diabetes Obes Metab， 2009,　11(1001-1008).
［50］Kovatchev B, Cobelli C, Renard E, et al. Multinational study of subcutaneous modelpredictive closedloop control in type 1 diabetes mellitus: summary of the results ［J］. J Diabetes Sci Technol， 2010,　4: 1374-1381.
［51］Weinzimer SA, Steil GM, Swan KL, et al. Fully automated closedloop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas ［J］. Diabetes Care， May 2008 2008,　31(5): 934-939.
［52］Steil GM, Rebrin K, Darwin C, et al. Feasibility of automating insulin delivery for the treatment of type 1 diabetes ［J］. Diabetes， 2006,　55(12): 3344-3350.
［53］Castle JR, Engle JM, El YJ, et al. Novel use of glucagon in a closedloop system for prevention of hypoglycemia in type 1 diabetes ［J］. Diabetes Care， 2010,　33: 1282-1287.
［54］ElKhatib FH, Jiang J, Damiano ER. A feasibility study of bihormonal closedloop blood glucose control using dual subcutaneous infusion of insulin and glucagon in ambulatory diabetic swine ［J］. J Diabetes Science and Technology， 2009,　3: 789-803.
［55］Microsoft Research Connections Team. Functional lens promises to improve the quality of life for diabetics and others ［EB/OL］. http://blogs.msdn.com/b/msr_er/archive/2011/07/27/functionallenspromisestoimprovethequalityoflifefordiabeticsandothers.aspx, 2011-07-27/2012-07-01. 
［56］Schaepelynck P, Darmon P, Molines L, et al. Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps ［J］. Diabetes Metab， Dec 2011,　37: S85-S93.
［57］Vaughn DE, Yocum RC, Muchmore DB, et al. Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase ［J］. Diabetes Technology & Therapeutics， Jun 2009,　11(6): 345-352.
［58］Steiner S, Hompesch M, Pohl R, et al. A novel insulin formulation with a more rapid onset of action ［J］. Diabetologia， Sep 2008,　51(9): 1602-1606.
［59］Raz I, Weiss R, Yegorchikov Y, et al. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an openlabel, randomized, twoperiod, oneway crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion ［J］. Clin Ther， 2009,　31(5): 980-987.
［60］Pettis RJ, Ginsberg B, Hirsch L, et al. Intradermal microneedle delivery of insulin Lispro achieves faster insulin absorption and insulin action than subcutaneous injection ［J］. Diabetes Technology & Therapeutics， Apr 2011,　13(4): 435-442.
［61］Cobelli C, Dalla Man C, Sparacino G, et al. Diabetes: models, signals, and control ［J］. IEEE Reviews in Biomedical Engineering， 2009,　2: 54-96.
［62］Harvey RA, Wang Y, Grosman B, et al. Quest for the artificial pancreas: combining technology with treatment ［J］. IEEE Engineering in Medicine and Biology Magazine， 2010,　29: 53-62 
［63］Wang Y, Dassau E, Doyle III FJ. Closedloop control of artificial pancreatic betacell in type 1 diabetes mellitus using model predictive iterative learning control ［J］. IEEE T Biomedical Engineering， 2010,　57: 211-219.
［64］Tsalikian E, Mauras N, Beck RW, et al. Impact of exercise on overnight glycemic control in  children with type 1 diabetes mellitus ［J］. Journal of Pediatrics， 2005,　147(4): 528-534.
［65］Bussau VA, Ferreira LD, Jones TW, et al. A 10s sprint performed prior to moderateintensity exercise prevents early postexercise fall in glycaemia in individuals with type 1 diabetes ［J］. Diabetologia， 2007,　50(9): 18151818.
［66］Breton MD. Physical activity—the major unaccounted impediment to closed loop control ［J］. J Diabetes Sci Technol， 2008,　2: 169-174.